The tumorigenicity assay indicated an obvious decrease in subcutaneous tumor volumes when ZNF148 was knocked down in t‐DCs, and this effect could be partially reversed by the simultaneous upregulation of PTX3 (Figure 6F). Here, ZNF148 is linked to neoplasm.